RDHL is RedHill Biopharma Ltd. (Healthcare) — a non-dividend-paying stock. Trading at $0.71. Market cap: $4M.
Stock snapshot
| Price | $0.71 |
| Market cap | $4M |
| Sector | Healthcare |
| Exchange | NCM |
| Pays dividend | No |
About RDHL
RedHill Biopharma Ltd is a specialty biopharmaceutical company mainly focused on the U.S. development and commercialization of drugs for GI diseases, infectious diseases, and oncology. The Company is mainly focused on the advancement of its development pipeline of clinical-stage therapeutic candidates and also commercializes its GI-related product, Talicia (omeprazole, amoxicillin, and rifabutin) in the U.S. Its therapeutic candidates include opaganib, RHB-204, RHB-104, RHB-102 (Bekinda), and RHB-107.
Related non-dividend companies
Other non-dividend stocks investors research alongside RDHL. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is RDHL's current stock price?
RDHL (RedHill Biopharma Ltd.) is currently trading at $0.71.
Does RDHL pay a dividend?
RDHL (RedHill Biopharma Ltd.) does not currently pay a regular dividend.
Track RDHL in DiviDrip
Add RDHL to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search RDHL and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-04. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.